300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Cryptocurrency
Oil and Gas
Retail
Payments
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Manufacturing
FinTech
Finance
Art
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Real Estate
Internet
Sporting Goods
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Ireland
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
North Bridge Venture Partners & Growth Equity, VC Fund

North Bridge Venture Partners & Growth Equity

VC Fund

Wellesley, United States

North Bridge Venture Partners & Growth Equity is a VC fund in Wellesley focused on Software and Enterprise Software. North Bridge provides seed-to-growth stage funding for businesses in several sectors such as software, communications and infrastructure, digital media, healthcare, and material production.North Bridge Venture Partners invests in exceptional people whose ideas have the potential to disrupt the way they live and work. They provide seed-to-growthfinancing to help transform those ideas into companies and those companies into market leaders.

Total investments:
276
Last investment:
Lead investor:
34%
Fund size:
$580M
Last fund:

Last updated:

Industries North Bridge Venture Partners & Growth Equity invests in

SoftwareEnterprise SoftwareSaaSMobileInformation Technology

Stages North Bridge Venture Partners & Growth Equity invests in

Series BSeries CSeries AFunding RoundSeries D

Countries North Bridge Venture Partners & Growth Equity invests in

United StatesCanadaIsraelThe NetherlandsUnited Kingdom

Round sizes

Series A $5M–$16MSeries B $8M–$37MSeries C $7M–$40M

Contacts

NameEmailPhoneSocials
See all 16 contacts →

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series A
$5M–$16M
Series B
$8M–$37M
Series C
$7M–$40M

Investment Focus

Industry

  • Software 46 (17%)
  • Enterprise Software 27 (10%)
  • SaaS 19 (7%)
  • Mobile 16 (6%)
  • Information Technology 16 (6%)
See all 191 industries →

Stage

  • Series B 58 (21%)
  • Series C 46 (17%)
  • Series A 39 (14%)
  • Funding Round 33 (12%)
  • Series D 27 (10%)
See all 15 stages →

Country

  • United States 122 (44%)
  • Canada 2 (1%)
  • Israel 2 (1%)
  • The Netherlands 2 (1%)
  • United Kingdom 1 (0%)

Team

NameTitleInvestmentsLinksEmail
Jeff McCarthy
Jeff McCarthy General Partner
General Partner Total investments: 18
Find email
Bill Burgess
Bill Burgess Operating Partner
Operating Partner Total investments: 7
Find email
Carmichael Roberts
Carmichael Roberts General Partner
General Partner Total investments: 147
Find email
Principal Total investments: 4
Find email
CFO Total investments: 0
Find email
See all 16 team members →

Investments

CompanyDescriptionRoundLinks
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat diseases. The company’s proprietary technology platform, XTreo, is designed to precisely and consistently delivermedicines directly to the affected tissue for sustained periods with a single administration. The company’s initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of CRS. The therapeutic embedded within LYR-210 and LYR-220 is mometasone furoate, which is the active ingredient in various FDA-approved drugs and has a well-established efficacy and safety profile. $50M / Post-IPO Equity / May 26, 2023
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat diseases. The company’s proprietary technology platform, XTreo, is designed to precisely and consistently delivermedicines directly to the affected tissue for sustained periods with a single administration. The company’s initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of CRS. The therapeutic embedded within LYR-210 and LYR-220 is mometasone furoate, which is the active ingredient in various FDA-approved drugs and has a well-established efficacy and safety profile. $100.5M / Post-IPO Equity / Apr 08, 2022
CubicPV is a solar industry that relies on legacy technologies with inherent limitations. Conventional solar modules convert sunlight to electricity using a single light-absorbing material and are nearing an efficiency threshold. $25M / Venture - Series Unknown / Jun 28, 2021
SmartAsset is an online destination for consumer-focused financial information and advice that powers SmartAdvisor, a national marketplace connecting consumers to financial advisors. Reaching approximately 75 million people each month (as of Sept. 2021) through its educational content and personalized calculators and tools, SmartAsset’s mission isto help people make smart financial decisions. Ranked on the Inc. 5000 list of fastest-growing private companies in 2021, SmartAsset recently closed a $110 million Series D round, valuing the company at over $1 billion. SmartAsset was also named to Y Combinator’s list of Top 100 Companies of all time, 2021 Best Financial Planning Technology Company in New York by Wealth & Finance International, and Forbes’ list of America’s Best Startup Employers in 2020. $110M / Series D / Jun 24, 2021
24M Technologies develops energy storage systems for grid and transportation applications. It offers binder-free semisolid electrodes and unit cells, eliminating the need for hydro or pyrometallurgical processes for battery recycling. It also helps direct in-plant reuse of active material for end-of-life recycling. $56.8M / Series E / May 27, 2021
Nasuni enables organizations to store, protect, synchronize and collaborate on files across all locations at scale. Nasuni Cloud File Services™, powered by the Nasuni UniFS® global file system, leverages cloud storage to modernize primary NAS and file server storage; archiving; backup; and disaster recovery, while offering transformational newcapabilities for multi-site file sharing. By combining the low cost, unlimited capacity, and durability of object storage from leading cloud vendors such as Amazon, Azure, Dell EMC, and IBM, with the high performance, security, and broad application compatibility of traditional file storage, the Nasuni subscription service improves workforce productivity, simplifies IT operations, and reduces IT costs. The world’s largest companies in 12 industry sectors rely on Nasuni to maximize the business value of their file data and ensure business continuity. $25M / Private Equity / Jul 14, 2020
Couchbase is a NoSQL cloud platform that provides a flexible data management solution for modern applications. It enables developers to efficiently store and retrieve data in JSON format, supporting high-performance operations. The platform offers features such as built-in caching, scalability, and analytics capabilities, allowing organizations tohandle large volumes of data seamlessly. Couchbase also supports various deployment options, including on-premises and cloud environments, catering to diverse business needs. By focusing on ease of use and integration, Couchbase helps teams build applications that require rapid data access and real-time analytics. $105M / Series G / May 21, 2020
Lyra Therapeutics, Inc. is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat diseases. The company’s proprietary technology platform, XTreo, is designed to precisely and consistently delivermedicines directly to the affected tissue for sustained periods with a single administration. The company’s initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of CRS. The therapeutic embedded within LYR-210 and LYR-220 is mometasone furoate, which is the active ingredient in various FDA-approved drugs and has a well-established efficacy and safety profile. $30M / Series C / Jan 29, 2020
1366 Technologies is a manufacturer of silicon wafers used to deliver solar modules. The company's silicon wafers leverage existing billion-dollar cell and module investments, enabling businesses to get a long-term, differentiated product roadmap. It was founded in 2008 and is headquartered in Bedford, Massachusetts. $18M / Series E / Dec 17, 2019
Xtalic offers unique nanostructured metal coatings that provide corrosion resistance, wear resistance and exceptional appearance across a wide range of applications, including decorative and functional metal finishing, as well as electronics. Xtalic's technology delivers premium performance through precisely and dynamically controlling metalstructure at the nanometer scale through a robust electroplating process. Xtalic's coating process is free of hexavalent chromium, reducing environmental compliance costs and worker safety hazards. Xtalic was founded in August of 2005 to commercialize the work of Professor Chris Schuh and Dr. Alan Lund of MIT. Debt Financing / Oct 01, 2019
See all 276 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Cryptocurrency
Oil and Gas
Retail
Payments
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Manufacturing
FinTech
Finance
Art
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Real Estate
Internet
Sporting Goods
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Ireland
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does North Bridge Venture Partners & Growth Equity invest in?

North Bridge Venture Partners & Growth Equity invests primarily in Software, Enterprise Software and SaaS startups, most often at Series B and Series C stage. Most of the 276 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is North Bridge Venture Partners & Growth Equity's check size?

North Bridge Venture Partners & Growth Equity typically joins rounds of $5M–$16M at Series A, $8M–$37M at Series B and $7M–$40M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds North Bridge Venture Partners & Growth Equity participates in.

How do I contact North Bridge Venture Partners & Growth Equity?

Public channels for North Bridge Venture Partners & Growth Equity include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at North Bridge Venture Partners & Growth Equity?

The team at North Bridge Venture Partners & Growth Equity includes Jeff McCarthy (General Partner), Bill Burgess (Operating Partner) and Carmichael Roberts (General Partner), among 16 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
North Bridge Venture Partners & Growth Equity North Bridge Venture Partners & Growth Equity Find emails